BioCentury
ARTICLE | Financial News

Ascentage hops in Hong Kong IPO queue

August 20, 2018 7:47 PM UTC

Ascentage Pharma Group International (Suzhou, China) proposed Monday to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by BofA Merrill Lynch and Citi.

The biotech's pipeline comprises seven clinical candidates in testing to treat cancer, HBV and age-related diseases, and includes small molecules against protein-protein interactions in the apoptosis pathway and next generation tyrosine kinase inhibitors. ...